Amylyx Pharmaceuticals
Senior Director, Chemistry, Manufacturing, and Controls (CMC) at Amylyx will lead the CMC organization to advance the company’s clinical-stage pipeline (including Avexitide and AMX0114). The role oversees development of robust, scalable processes with external CDMOs to support clinical and commercial supply and ensures CMC readiness across programs. This leader reports to the SVP, Global CMC and External Manufacturing and partners cross-functionally to align CMC strategy with program goals.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Amylyx Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including Post-Bariatric Hypoglycemia (PBH), Wolfram Syndrome, and Amyotrophic Lateral Sclerosis (ALS). Its lead program, Avexitide, is being evaluated in the pivotal Phase 3 LUCIDITY clinical trial for PBH. Amylyx advances its pipeline using rigorous science, well-defined mechanistic rationale, and a strong commitment to the patient communities it serves.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amylyx Pharmaceuticals.
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
4 days ago
Director, CMC – Small Molecule Chemistry
Pathos
Senior Director, Regulatory CMC
Centessa Pharmaceuticals
VP of CMC
Lindus Health
Senior Scientist 2, Chemical Development & Manufacturing
biomarin
Associate Director, Process Chemistry (External Manufacturing)
AbbVie
Director, Process Chemistry
IDEAYA Biosciences, Inc.